argenx SE (NAS:ARGX)
$ 356.01 -3.47 (-0.97%) Market Cap: 21.22 Bil Enterprise Value: 18.74 Bil PE Ratio: 0 PB Ratio: 5.39 GF Score: 74/100

Half Year 2020 argenx SE Earnings Call Transcript

Jul 30, 2020 / 12:30PM GMT
Release Date Price: $234.41 (-6.04%)
Operator

Welcome to argenx Half Year 2020 Financial Results and Second Quarter Business Update Conference Call. (Operator Instructions) To follow the presentation, we ask that you navigate the slides as directed by argenx management. (Operator Instructions)

I would now like to turn the conference over to Ms. Beth DelGiacco, Vice President of Investor Relations at argenx. Thank you.

Beth DelGiacco
argenx SE - VP of IR

Thank you. A press release was issued earlier today with our half year 2020 financial results and second quarter business update. This can be found on our website along with the presentation for today's webcast.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. argenx is not under any obligation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot